Cargando…
Plitidepsina, un inhibidor del factor de elongación celular eEF1a y molnupiravir un análogo del ribonucleósido citidina, dos nuevos compuestos químicos con intensa actividad frente al SARS-CoV-2
The knowledge of the replicative cycle of SARS-CoV-2 and its interactions with cellular proteins has opened a new therapeutic possibility based on blocking those essential for the virus. The cellular protein elongation factor eEF1A could be a good target. Among its natural inhibitors are didemnins a...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedad Española de Quimioterapia
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638831/ https://www.ncbi.nlm.nih.gov/pubmed/33902254 http://dx.doi.org/10.37201/req/042.2021 |